IHC showed that CAF-derived exosomes could upregulate Lin28A and Lin28B in CRC tumors, while 5-FU and L-OHP could downregulate Lin28A and Lin28B in CRC tumors or CAF-derived exosome-treated CRC tumors. This evidence concerns the gene LIN28A and colorectal carcinoma.